NCT06996353 Clinical Data Collection of Myopic Patients After PTK-PRK With CZM MEL 90 Excimer Laser
| NCT ID | NCT06996353 |
| Status | Recruiting |
| Phase | — |
| Sponsor | London Vision Clinic |
| Condition | Refractive Errors |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-05-26 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-05-26 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of the clinical investigation presented to is to verify predictions of post-operative PTK-PRK refractive outcome made by the EpiMaster application software by comparing these to post-operative clinical data after routine PTK-PRK treatments.
Eligibility Criteria
Inclusion Criteria: * Inclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors * Patient present with myopic or myopic and astigmatic error * Patient will be able to understand the patient information and willing to sign an informed consent * Patient will be willing to comply with all follow-up visits and the respective examinations Exclusion Criteria: * Exclusion criteria are according to the user manual of CZM MEL 90 Excimer Laser for treatment of refractive errors
Contact & Investigator
Dan Z Reinstein, MD
STUDY DIRECTOR
London Vision Clinic Ltd., London, United Kingdom
Frequently Asked Questions
Who can join the NCT06996353 clinical trial?
This trial is open to participants of all sexes, studying Refractive Errors. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06996353 currently recruiting?
Yes, NCT06996353 is actively recruiting participants. Contact the research team at timothy@londonvisionclinic.com for enrollment information.
Where is the NCT06996353 trial being conducted?
This trial is being conducted at Chandigarh, India, Chennai, India.
Who is sponsoring the NCT06996353 clinical trial?
NCT06996353 is sponsored by London Vision Clinic. The principal investigator is Dan Z Reinstein, MD at London Vision Clinic Ltd., London, United Kingdom. The trial plans to enroll 150 participants.